News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Privia Health's Q2 results showed strong revenue growth but missed non-GAAP profit expectations, leading to a negative market reaction. Management attributed revenue growth to robust provider signings and expanded value-based attributed lives. This article highlights the top five analyst questions from the earnings call, …
Privia Health Group (PRVA) reported strong Q2 2026 results with increased sales and net income, alongside a raised full-year 2026 revenue outlook to the high end of its previous guidance. Despite this positive financial performance, the stock fell 5.2%. The company's investment narrative centers …
Privia Health Group (PRVA) reported strong Q2 2026 results with increased sales and net income, leading management to raise its 2026 GAAP revenue expectations to the top end of its prior guidance range of US$2.35–US$2.45 billion. Despite this positive news and continued expansion into …
Privia Health Group's stock saw a modest rise after its Q2 earnings report, which highlighted a 21.4% revenue increase to US$632.6m and adjusted EBITDA growth of 29% to US$37.4m, leading management to lift full-year guidance. While bulls see this as evidence of scale and …
Privia Health Group Inc (NASDAQ:PRVA) is scheduled to release its Q2 2026 earnings on August 6, 2026, with revenue estimates at $599.19 million and earnings at $0.07 per share. Analyst price targets suggest an average upside of 33.58% from the current price, while GuruFocus …
This article provides a detailed financial overview of Privia Health Group, Inc. (PRVA), including its stock price, historical data, key financial metrics, and analyst ratings. As of August 7, 2026, PRVA's stock closed at $22.45, up 2.05%, with a market capitalization of $2.868 billion …
Privia Health Group, Inc. (NASDAQ:PRVA) has received an average "Moderate Buy" rating from brokerages, with eleven out of fourteen analysts recommending a buy. The average 12-month price target is $31.15, significantly higher than its current trading price of $23.96. Despite significant insider selling totaling …
The article focuses on the enterprise value to EBIT forward for Privia Health Group, Inc. (NASDAQ: PRVA). It presents financial data and market information related to the company, including its stock market listing on Nasdaq. The content seems to be a snapshot from a …
Privia Health Group, Inc. (PRVA) reported strong results for 2026, with revenue reaching $632.63 million and diluted EPS of $0.07. This growth was fueled by an expanding provider network and increased visit volumes. The company also saw significant shifts towards value-based care, with attributed …
Privia Health (PRVA) reported strong Q2 2026 results with revenue up 21.4% to $632.6 million and net income soaring 236.7% to $9.0 million. The company raised its full-year 2026 guidance for GAAP revenue to the high end of $2.35–$2.45 billion and Adjusted EBITDA to …
Privia Health Group, Inc. (PRVA) published its Q2 2026 earnings call presentation. The company reported an EPS of $0.19, missing estimates by $0.05, but revenue reached $632.63M, beating expectations by $31.87M and representing a 21.39% year-over-year increase. This presentation was released in conjunction with …
PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 21.4% year on year to $632.6 million. Its non-GAAP profit of $0.19 …
Privia Health Group Inc (PRVA) shares fell 8.2% to $22.00, but are considered undervalued by the GF Value™ estimate of $27.63, creating a 20.4% margin of safety. The company has a strong GF Score™ of 88/100, with high ratings for growth and valuation, despite …
Privia Health Group, Inc. (PRVA) announced its Q2 revenue of $632.6 million, significantly surpassing the FactSet estimate of $597.3 million. This indicates stronger-than-anticipated financial performance for the quarter.
This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Privia Health Group Inc (NASDAQ:PRVA) delivered strong operational execution with implemented provider growth of 10.1% …
Privia Health Group (PRVA) exceeded Q2 2026 earnings expectations, reporting adjusted EPS of $0.19 against a $0.07 estimate, and revenue of $632.6M, a 21.4% increase year-over-year. The company's growth was driven by its expanding provider network and value-based care arrangements, with full-year revenue guidance …
Privia Health Group, Inc. (NASDAQ: PRVA) reported significant financial growth for Q2 2026, with revenue increasing to $632.6 million and net income rising to $9.0 million. The company also expanded its revolving credit facility to $250 million with no outstanding borrowings, demonstrating strong liquidity. …
Privia Health (NASDAQ:PRVA) Surprises With Q2 CY2026 Sales Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 21.4% year on year to $632.6 million. Its non-GAAP profit was $0.19 per share. Is now …
Privia Health Group, Inc. (NASDAQ:PRVA) reported strong second-quarter results, exceeding analyst expectations with adjusted EPS of $0.19 and revenue of $632.6 million. The company also issued its first fiscal year 2026 revenue guidance, projecting between $2.35 billion and $2.45 billion, with the midpoint slightly …
Privia Health Group (PRVA) announced strong second-quarter 2026 financial results, with net income rising 236.7% to $9.0 million and adjusted EBITDA increasing 29.1% to $37.4 million. Total revenue grew 21.4% to $632.6 million, leading the company to raise its full-year 2026 guidance across all …
Privia Health Group, Inc.'s average stock price target has increased from $31.89 to $32.11, according to estimates from 18 analysts. This updated target implies a 35% potential upside based on the Aug. 4 closing price, with forecasts ranging from $24 to $40 per share. …
Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Privia Health Group Inc. is set to report its second-quarter earnings, with analysts expecting a significant rebound in profit to 7 cents per share after a disappointing first quarter. Investors will be focused on whether the company can demonstrate sustainable profitability, continued revenue growth, …
Privia Health Group (NASDAQ: PRVA) is set to report its Q2 earnings, with analysts expecting a 14.6% year-on-year revenue growth. The company has a history of exceeding Wall Street's expectations and beat revenue estimates last quarter, despite missing EPS estimates. Investors will be watching …
This article provides an AI-driven analysis of Privia Health Group Inc. (NASDAQ: PRVA), highlighting weak near and mid-term sentiment and a neutral long-term outlook. It identifies an exceptional 36.9:1 risk-reward short setup and outlines specific institutional trading strategies for long, momentum breakout, and short …
This article provides a technical analysis of Privia Health Group Inc (PRVA), detailing its current price momentum, support and resistance levels, and various technical indicators and moving averages. The analysis indicates PRVA's stock is currently trading between resistance at $27.28 and support at $21.99, …
This article provides a comprehensive stock analysis of Privia Health Group Inc (PRVA) by TradingKey, assigning it a score of 6.91/10. Key insights highlight healthy fundamentals, high growth potential, and a fairly valued assessment, ranking 21st in its industry. The report notes high institutional …
Revelio Labs reports that Privia Health Group, Inc. (PRVA) had approximately 1,249 employees worldwide as of March 2026, marking an 11.8% growth since 2023 but a 0.3% decline year-over-year in 2026. The company is actively hiring, though job postings decreased by 28.7% in 2026. …
Search by ticker symbol or company name and select a result to open its chart.